| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.500 | None | 0.964 | 8 | 4 | 1995 | 2020 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.500 | None | 0.937 | 5 | 2 | 1997 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.200 | None | 0.958 | 9 | 9 | 2005 | 2019 | |||||||||
|
protein C receptor | 0.560 | 0.692 | 5.6E-03 |
|
phenotype | 0.200 | None | 0.875 | 4 | 5 | 2001 | 2019 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.200 | None | 1.000 | 1 | 1 | 1999 | 2019 | ||||||||
|
coagulation factor X | 0.493 | 0.769 | 2.3E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 1 | 2008 | 2020 | ||||||||
|
coagulation factor VIII | 0.542 | 0.769 | 1.00 |
|
phenotype | 0.180 | None | 1.000 | 1 | 1 | 2002 | 2019 | ||||||||
|
fibrinogen gamma chain | 0.633 | 0.615 | 5.0E-02 |
|
phenotype | 0.160 | None | 1.000 | 1 | 2 | 2011 | 2019 | ||||||||
|
coagulation factor XI | 0.590 | 0.692 | 3.6E-26 |
|
phenotype | 0.140 | None | 1.000 | 5 | 7 | 2011 | 2020 | ||||||||
|
solute carrier family 44 member 2 | 0.743 | 0.462 | 1.2E-04 |
|
phenotype | 0.140 | None | 0.833 | 4 | 3 | 2015 | 2020 | ||||||||
|
tetraspanin 15 | 0.780 | 0.346 | 8.0E-03 |
|
phenotype | 0.120 | None | 0.833 | 5 | 2 | 2015 | 2020 | ||||||||
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
phenotype | 0.120 | None | 1.000 | 1 | 1 | 2015 | 2019 | ||||||||
|
lymphocyte antigen 86 | 0.805 | 0.231 | 2.3E-05 |
|
phenotype | 0.120 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
zinc finger protein, FOG family member 2 | 0.565 | 0.731 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
NME/NM23 family member 7 | 0.729 | 0.423 | 4.0E-06 |
|
phenotype | 0.110 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit S3 | 0.581 | 0.769 | 5.8E-04 |
|
phenotype | 0.110 | None | 0.500 | 1 | 1 | 2018 | 2019 | ||||||||
|
beta-1,3-glucuronyltransferase 2 | 0.931 | 0.115 | 3.3E-05 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ZFPM2 antisense RNA 1 | 0.736 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||||||
|
FUN14 domain containing 2 | 0.760 | 0.385 | 6.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
complement component 4 binding protein alpha | 0.556 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
F11 antisense RNA 1 | 0.805 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2011 | 2019 | |||||||||
|
phospholipase C gamma 2 | 0.588 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
G protein-coupled receptor kinase 5 | 0.588 | 0.769 | 0.68 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
OSMR antisense RNA 1 (head to head) | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 |